Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Appears that Holdings has voted to approve the amalgamation

<< Previous

Bullboard Posts

Next >>

Comment by Forestviewon May 28, 2021 2:14pm

128 Views

Post# 33287397

RE:RE:RE:Appears that Holdings has voted to approve the amalgamation

So, the AH shares aren't hitting ATE until mid week now? I thought it was going to be May 31?

GameChangerBet wrote: Not necessarily a major catalyst but certainly one more obstacle officially out of the way.
In terms of Nasdaq listing, I would bet that they will do this when they have a partnership ready. There may be some other positive developments between now and the end of the year, enough to move the stock price to get the uplist, then follow it up with a partnership announcement to move the share price after it's listed.
You want major follow through news after listing, not only to maintain the price but have it increase aggressively with a major development (partnership).
Combine that with an influx of institutional US money, and the momentum will carry itself.

Use the Nuance deal as an example.
Uplist to TSX, announce the deal, raise the required capital on the share price increase.
Similar strategy with Nasdaq.
Diferrence this time will be the stock will be free to run, no cap.

MrMugsy wrote:

markymark11 wrote: From ceo.ca/ate:

Holdings voted and passed amalgamation unanimously

In regards to timing... there was a question from a Holdings shareholder on timing (basically when would Holdings Shareholders get their shares of ATE)

They said they were hoping next Wednesday or Thursday (and essentially 3 days after that for drs (direct registration system) to be in their email)

I'm not sure if there'll be an ATE news release on Monday about amalgamation (or whether it'll be that mentioned Wednesday or Thursday)

Thanks Marky ... if treated like any other shareholder vote ... results could be communicated on the same day - but - who knows in this case. 3 people with more than 50% of the votes ... it was already a done deal (in my mind).

Really looking for an official date so mid-week works as good as any date.

I can't see this being a major catalyst on it's own (just retail investor excitement to move the price around right now).

It's what comes from it that excites me. If we're going to the NASDAQ by Fall, lots to be shared before then ... IMO. Let's see.